Eli Lilly blows past quarterly estimates, posts strong outlook as Zepbound and Mounjaro sales soar

Sports quarter results out from Eli Liy. $7.54% a share beat estimates of 667 a share. Uh revenue of 19.3% billion.All right, we're going to have to figure this out. Look at that stock. Uh up 7% back over $1,000 of 17.9% billion.Um fourth quarter volumes rose 76%. Realized prices though fell 5%. Zepbound and Monaro sales more than doubled year-over-year.and those were well above expectations and that the company also uh issued upbeat fullear guidance. So it's the opposite thing we're looking for here. What ...